Mar 2022 $1 M No. 7 Under $2 million 1
Genenews Ltd.: Raise no. 7, Mar 2022 × Investors in this round 1 investor had bought by the notice of Mar 17, 2022: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $3 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Each unit consists of one common share and one transferable share purchase warrant. Each whole warrant is exercisable for one additional share until March 2, 2026 at Cdn$0.2206 per share. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue $5 million to $25 million
Sales commissions $227,882
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Ontario, Canada People named in the notice James R. Howard-Tripp · Executive Officer, Director Garth R. MacRae · Director Harry R. Glorikian · Director Richard Janice Huston · Director Rory Janice Riggs · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in NY Remarks in the notice On fees: “Includes broker warrants to purchase 800,000 common shares of the issuer at Cdn$0.2206 per share for a period of 4 years.”On the amounts: “The additional $1,741,396.00 may be received upon the exercise of share purchase warrants sold inside or outside the U.S. Dollar amounts are based on the Bank of Canada average rate of exchange reported on March 2, 2022, which wad Cdn$1.2668=USD$1.00.”On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”Signed by Matthew Peitras, Cfo & coo. Source: SEC Form D, newest notice filed Mar 17, 2022. Read the notice at the SEC .
equity, options SEC Nov 2021 $3 M No. 6 $2 to $10 million 6
Genenews Ltd.: Raise no. 6, Nov 2021 × Investors in this round 6 investors had bought by the notice of Feb 7, 2022: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $7 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Each unit consists of one common share and one transferable share purchase warrant. Each whole warrant is exercisable for one additional share until November 25, 2025 at Cdn$0.56 per share. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue $1 million to $5 million
Sales commissions $524,960
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Ontario, Canada People named in the notice James R. Howard-Tripp · Executive Officer, Director Garth R. MacRae · Director Harry R. Glorikian · Director Richard Janice Huston · Director Rory Janice Riggs · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in NY, TX Remarks in the notice On fees: “Includes broker warrants to purchase750,000 common shares of the issuer at Cdn$0.56 per share for a period of 4 years.”On the amounts: “The additional $4,110,877.00 may be received upon the exercise of share purchase warrants sold inside or outside the U.S. Dollar amounts are based on the Bank of Canada average rate of exchange reported on November 26, 2021, which wad Cdn$1.2771=USD$1.00.”On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”Signed by James Howard-Tripp, Chairman and CEO. Source: SEC Form D and 1 amendment, newest notice filed Feb 7, 2022. Read the notice at the SEC .
equity, options SEC Jun 2018 $2 M No. 5 Under $2 million 1
Genenews Ltd.: Raise no. 5, Jun 2018 × Investors in this round 1 investor had bought by the notice of Jun 22, 2018: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Each warrant is exercisable for one common share at an exercise price of CDN$0.096 for a period of 36 months. The convertible note has a 30 month term and bears interest of 8% per annum. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Ontario, Canada People named in the notice James Howard-Tripp · Executive Officer, Director Leslie Auld · Executive Officer, Director Garth MacRae · Director Harry Glorikian · Director Rory Riggs · Director Thomas Stewart Jr. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The additional $1,001,429.00 may be received upon the exercise of share purchase warrants sold inside and outside the U.S. U.S. dollar amounts are based on the Bank of Canada average rate of exchange reported on June 7, 2018, which was CDN$1.2972=US$1.00.”On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”Signed by James Howard-Tripp, Ceo. Source: SEC Form D, newest notice filed Jun 22, 2018. Read the notice at the SEC .
equity, debt, options SEC Jul 2014 $6 M No. 4 $2 to $10 million 8
Genenews Ltd.: Raise no. 4, Jul 2014 × Investors in this round 8 investors had bought by the notice of Jul 22, 2014: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $7 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Ontario, Canada People named in the notice James C. Howard-Tripp · Executive Officer, Director Leslie Auld · Executive Officer, Director Floyd C. Dent III · Director Garth C. MacRae · Director Harry C. Glorikian · Director Heiner Dreismann · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Leslie Auld, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 22, 2014. Read the notice at the SEC .
equity SEC Dec 2012 $6 M No. 3 $2 to $10 million 14
Genenews Ltd.: Raise no. 3, Dec 2012 × Investors in this round 14 investors had bought by the notice of Dec 28, 2012: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Ontario, Canada People named in the notice Gailina Liew · Executive Officer, Director Heiner Dreismann · Executive Officer, Director Karl Wassmann · Executive Officer Leslie Auld · Executive Officer David Sable · Director Garth MacRae · Director Harry Glorikian · Director James Howard-Tripp · Director Rory Riggs · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Sales were made to U.S. purchasers in 3 tranches on December 14, 17 & 18, 2012. The applicable noon exchange rate, as issued by the Bank of Canada, was used to calculate the aggregate total offering amount on each date of the respective tranches.”Signed by Leslie Auld, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 28, 2012. Read the notice at the SEC .
equity SEC Jun 2011 $5 M No. 2 $2 to $10 million 11
Genenews Ltd.: Raise no. 2, Jun 2011 × Investors in this round 11 investors had bought by the notice of Jun 23, 2011: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Ontario, Canada People named in the notice Gailina A Liew · Executive Officer, Director Heiner Dreismann · Executive Officer, Director Leslie A Auld · Executive Officer David A Sable · Director Garth MacRae · Director Harry A Glorikian · Director James Howard-Tripp · Director Rory Riggs · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Working capital, expanding access to the ColonSentry(TM) test in Canada, the United States, Europe and Asia, and pipeline development.”Signed by Gailina Liew, Chief Operating Officer. Source: SEC Form D, newest notice filed Jun 23, 2011. Read the notice at the SEC .
equity, options SEC Nov 2010 $1 M No. 1 Under $2 million 7
Genenews Ltd.: Raise no. 1, Nov 2010 × Investors in this round 7 investors had bought by the notice of Nov 26, 2010: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity, debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Ontario, Canada People named in the notice Gailina A Liew · Executive Officer, Director Heiner Dreismann · Executive Officer, Director Leslie A Auld · Executive Officer David A Sable · Director Garth MacRae · Director Harry A Glorikian · Director James Howard-Tripp · Director Rory Riggs · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “General working capital purposes, the continued marketing of the ColonSentry test in Canada and the pre-launch preparation for the commercial launch of the ColonSentry test into the United States and Asia.”Signed by Leslie Auld, Chief Financial Officer and Treasurer. Source: SEC Form D, newest notice filed Nov 26, 2010. Read the notice at the SEC .
equity, debt, options SEC